Dialogue Health Technologies Files to List on TSX

Posted on March 9, 2021 by Mathieu Litalien

Here we go again - Dialogue Health Technologies, yet another virtual health company, filed its preliminary prospectus to list on the TSX Index. Although financial details include price and expected $$ raised have not yet been released, this will be a very interesting one to watch. The company has some big players backing it such as Sunlife Financial (TSX:SLF). Combined wiht the other large institutional shareholders, they own 63% of the pre-IPO outstanding shares. 

Unlike some of the more recent virtual tech IPOs, Dialogue is a well established company. Take a look at these numbers:

These are much better than any of the newly listed virtual health care stocks. Unlike some of the others as well, Dialogue is truly a virtual health care pureplay. In 2020, it also expanded to Germany which opens up a slew of other international opportunities in the EU. 

Once pricing is released we will provide more details, but after the slew of disappointing health care IPOs recently - we think this one will stand out. 


News Release


Not for distribution to U.S. news wire services or dissemination in the United States.

Montréal, Québec, March 8th, 2021 – Dialogue Health Technologies Inc. (“Dialogue” or the “Company”) announced today that it has filed with the securities regulatory authorities in each of the provinces and territories of Canada, and obtained a receipt for, a preliminary long-form prospectus (the “Preliminary Prospectus”) for a proposed initial public offering of common shares (the “Offering”). The price of the common shares to be sold has not yet been determined.

The Offering is being made through a syndicate of underwriters led by National Bank Financial Inc., RBC Capital Markets, Scotiabank and TD Securities Inc. as joint bookrunners and including CIBC World Markets Inc., Desjardins Securities Inc., Canaccord Genuity Corp., iA Private Wealth Inc., INFOR Financial Inc. and Laurentian Bank Securities Inc.

The Preliminary Prospectus contains important information relating to Dialogue, the common shares and the Offering and is still subject to completion or amendment. Copies of the Preliminary Prospectus are available on SEDAR at www.sedar.com. There will not be any sale or any acceptance of an offer to buy the common shares until a receipt for the final prospectus has been issued.

No securities regulatory authority has either approved or disapproved the contents of this news release. This news release does not constitute an offer to sell or the solicitation of an offer to buy any securities of Dialogue in any jurisdiction in which such offer, solicitation or sale would be unlawful.

The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities laws, and may not be offered, sold or delivered, directly or indirectly, in the United States (as defined in Regulation S under the U.S. Securities Act). Accordingly, the securities may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to exemptions from the registration requirements of the U.S. Securities Act and applicable state securities laws.

About Dialogue

Incorporated in 2016, Dialogue is Canada’s premier virtual healthcare and wellness platform, providing affordable, on-demand access to quality care. Through our team of health professionals, we serve employers and organizations who have an interest in the health and well-being of their employees, members and their families. Our Integrated Health Platform™ is a one-stop healthcare hub that centralizes all of our programs in a single, user-friendly application, providing access to Services 24 hours per day, 365 days per year from the convenience of a smartphone, computer or tablet.

For further information, please contact:

Investor relations
Navaid Mansuri
Chief Financial Officer

Media Relations
Jean-Christophe de Le Rue
Director of Public and Government Relations
press@dialogue.co / 613-806-0671

Disclaimer: The writer of this article or employees of Stocktrades Ltd may have positions in securities listed in this article. Stocktrades Ltd may also be compensated via affiliate links in this post. Stocktrades Ltd will run advertisements on our posts. These advertisements do not represent an endorsement by us.

Mathieu Litalien

About the author

Mathieu is an individual investor and has been investing part-time for the better part of the past 20 years. He is primarily interested in fundamental analysis, focusing on the long-term and his portfolio is composed primarily of dividend-paying equities. Mathieu has a moderate risk profile and also looks for growth and value. His passion for finance and the markets have led him to his MBA and writing for Seeking Alpha and Stocktrades. Mathieu also focuses primarily on stock research and content production for Stocktrades.ca Premium and the Stocktrades blog.